补阳还五汤治疗卡培他滨相关性手足综合征的临床观察  

Clinical observation on Buyanghuanwutang in treating hand-foot syndrome caused by capecitabine

作　　者：杨兵[1] 蔡韶芳[1] 潘莹[1] 杜均祥[1] 梁翠微[1] 彭东旭[1] 

机构地区：[1]珠海市人民医院,广东519000

出　　处：《齐齐哈尔医学院学报》2016年第7期881-882,共2页Journal of Qiqihar Medical University

摘　　要：目的对补阳还五汤治疗卡培他滨导致手足综合征的治疗效果进行观察。方法选取我院52例手足口综合征患者,随机分为观察组与对照组,观察组27例患者,对照组25例患者;对照组采用常规化疗方法治疗,观察组采用化疗联合补阳还五汤治疗,对比两组的疗效。结果在治疗后两组手足综合征发生率为,观察组51.80%,对照组为64.00%,两组间比较有显著差异(P<0.05)。结论在治疗中应用补阳还五汤防治卡培他滨相关性的手足综合征,效果显著,值得推广。Objective Aimed to observe efficacy of Buyanghuanwutang in the treatment of hand- foot syndrome caused by capecitabine. Methods 52 cases of hand- foot syndrome in our hospital were randomly divided into observation group and control group,27 patients in observation group and 25 patients in the control group. The control group was given conventional chemotherapy treatment,while observation group received chemotherapy combined Buyanghuanwutang. The therapeutic effects of the two groups were compared. Results The occurrence rate of HFS in the observation group was 51. 80% and it was 64. 00% in the control group,there was a significant difference between the two groups（ P〈0. 05）. Conclusions Application of Buyanghuanwutang in treatment of capecitabine correlation hand- foot syndrome can obtain significant effect,it is worth promoting.

关 键 词：补阳还五汤 手足综合征 卡培他滨 

分 类 号：R738.5[医药卫生—肿瘤]